Abstract
A previous genome-wide association study (GWAS) exposed histone deacetylase 2 (HDAC2) as a possible candidate gene for breast muscle weight in chickens. The present research has examined the possible role of HDAC2 in skeletal muscle development in chickens. Gene expression was measured by quantitative polymerase chain reaction in breast and thigh muscles during both embryonic (four ages) and post-hatch (five ages) development and in cultures of primary myoblasts during both proliferation and differentiation. The expression of HDAC2 increased significantly across embryonic days (ED) in breast (ED 14, 16, 18, and 21) and thigh (ED 14 and 18, and ED 14 and 21) muscles suggesting that it possibly plays a role in myoblast hyperplasia in both breast and thigh muscles. Transcript abundance of HDAC2 identified significantly higher in fast growing muscle than slow growing in chickens at d 90 of age. Expression of HDAC2 during myoblast proliferation in vitro declined between 24 h and 48 h when expression of the marker gene paired box 7 (PAX7) increased and cell numbers increased throughout 72 h of culture. During induced differentiation of myoblasts to myotubes, the abundance of HDAC2 and the marker gene myogenic differentiation 1 (MYOD1), both increased significantly. Taken together, it is suggested that HDAC2 is most likely involved in a suppressive fashion in myoblast proliferation and may play a positive role in myoblast differentiation. The present results confirm the suggestion that HDAC2 is a functional gene for pre-hatch and post-hatch (fast growing muscle) development of chicken skeletal muscle.
Keywords: Histone Deacetylase 2, Post Genome-Wide Association Study, Gene Expression, Myogenesis
INTRODUCTION
Muscle growth follows a distinct two-stage process, hyperplasia and hypertrophy, which is similar in mammals and poultry (Rehfeldt et al., 2011). Hyperplasia describes the increase in myoblast cell number. During the embryonic period of muscle development, myoblasts are proliferating, then differentiating into multinucleated myotubes, and finally forming muscle fibers. After the pre-hatch formation of muscle fibers, fiber number is almost fixed by the time of hatch (Velleman, 2007).
The poultry industry has largely selected animals based on phenotypic growth rate and muscling. By using this approach, it has likely favored selection based on muscle hypertrophy rather than on hyperplasia, which might result in a situation that could be detrimental to muscle health and subsequently meat quality. As increasing evidence suggests that influences on prenatal development of skeletal muscle can result in long-term effects on postnatal growth and physiological function in farm animals, there is a need to expose genes which function prenatally in muscle development. Several candidate genes influencing breast or thigh muscle weights were identified from our previous genome-wide association study (GWAS) on chickens (Liu et al., 2013).
The possible association of the histone deacetylase 2 (HDAC2) gene with skeletal muscle development in chickens was the focus of the present study. HDAC2 is a class-I enzyme (typically localizes to the cell nucleus) belonging to HDAC enzyme family which deacetylates histone tails and non-histone proteins changing chromatin structure (Montgomery et al., 2007). The structure of chromatin is an important factor for DNA-related processes in eukaryotes (Lin et al., 2008) by regulating many important cellular processes including transcription (Brunmeir et al., 2009) and control of cell growth, differentiation, and development of skeletal muscle (McKinsey et al., 2001). HDAC2 is expressed in many tissues and plays a crucial role in cellular differentiation and proliferation (Segré and Chiocca, 2011). There has been, however, no functional or mechanistic investigation of this gene in the development of chicken skeletal muscle.
In vitro, skeletal myogenesis follows a defined pattern of temporal gene expression (Bentzinger et al., 2012). Four myogenic regulatory factors (MRFs), products of myogenic factor 5 (MYF5), myogenic differentiation (MYOD), myogenin (MYOG), and myogenic regulatory factor 4 (MRF4) genes, are sequentially expressed during myogenesis where MYOD is required for inducing differentiation and formation of muscle fibers (Rehfeldt et al., 2011). In addition to these MRFs, two myogenic inducers, paired box 3 (PAX3) and 7 (PAX7), play a vital role in skeletal muscle development (Lamey et al., 2004); PAX7 serves as a marker of muscle precursor cells during myogenesis (Halevy et al., 2004).
In the present study, the role of the HDAC2 gene in muscle development of chickens was examined by measuring the relative expression of HDAC2 in breast and thigh muscles at embryonic and post-hatch stages. The relative expression profiles of HDAC2 were also examined during primary myoblast proliferation and differentiation.
MATERIALS AND METHODS
Ethics statement
All experimental procedures with Beijing-You chicks and embryos were performed according to the Guidelines for Experimental Animals established by the Ministry of Science and Technology (Beijing, China). All experimental protocols were approved by the Science Research Department (in charge of animal welfare issues) of the Institute of Animal Sciences, CAAS (Beijing, China). The chicks and incubating eggs were obtained from the experimental farm of the Institute of Animal Sciences (IAS), Chinese Academy of Agricultural Sciences (CAAS), Beijing, China.
Tissue sample collection
Embryonic breast and thigh tissue samples were collected from six randomly chosen embryos on embryonic day (ED) 14, 16, 18, and 21. Similar samples were collected at d 1, 7, 14, 21, and 28 after hatching including deboned muscles from breast (right side) and thigh (left side) for weight, in addition, lowest and highest growth of breast muscles samples were collected from 90 d old chickens. All samples were snap frozen in liquid nitrogen and held at −80°C, except deboned muscles.
Preparation and culture of chicken primary myoblasts
The pectoralis muscles were collected from ED 12 embryos into phosphate-buffered saline (PBS). The muscle pieces were washed twice after removing visible connective tissue and blood vessels. The pieces were then minced and digested for 30 min at 37°C with 2 volumes of PBS containing 0.1% collagenase I (Gibco, Carlsbad, CA, USA), 1.5% bovine serum albumin and 100 millimolar (mM) N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid. The supernatant after centrifuging (7 min, room temperature, 1,000×g) was discarded. Digestion was repeated a second time with 2 volumes of PBS containing 0.25% trypsin and 0.04% ethylenediaminetetraacetic acid for 15 min at 37°C. Cells were then liberated by repeated pipetting after adding an additional 2 volumes of Dulbecco’s modified eagle medium/nutrient mixture F-12 (DMEM/F-12) (HyClone, Waltham, MA, USA) with 15% fetal bovine serum (FBS) (HyClone, USA) to quench enzyme action. The muscle digests were sieved sequentially over screens of 149, 74, 37, and 23 μm porosity and myoblasts were collected by centrifugation, as above. Erythrocytes were eliminated by lysis for 8 min then myoblasts were recovered and washed again with PBS and centrifugation, then suspended in medium DMEM/F-12 containing 15% FBS and 1% Penicillin-Streptomycin (HyClone, USA). Cells were seeded at about 1.5×106/well in 6-well plates and 104/well in 96-well plates and incubated at 37°C under 5% CO2 in air. Culture medium was replaced daily for 60 h then, when cells were at about 80% confluency, FBS was replaced with 2% horse serum (Gibco, USA) to induce myoblast differentiation.
Myoblast proliferation
The number of live myoblasts was measured at 24 h, 48 h, and 72 h of the initial cell culture. Medium was removed from each well (8 wells in a 96-well plate) and replaced with 100 μL fresh medium containing 10% (v/v) cell counting kit 8 (CCK-8) (Dojindo, Kumamoto, Japan) reagents. The tetrazolium salt of this reagent was reduced by dehydrogenase activities of live cells to produce a yellow formazan dye in the culture media that can be quantified (after 3 h) by measuring absorbance at 450 nanometer (nm).
Characterization of myotubes
Differentiating myoblasts were washed with PBS and fixed in 4% paraformaldehyde solution for 10 min at 24 h, 72 h and 144 h of differentiation to visualize myotubes and nuclei. Cells were then stained with Giemsa (Amresco, Solon, OH, USA) for 10 min. Total cell nuclei and nuclei within myotubes (≥3 nuclei) were counted manually from five randomly chosen microscopic fields. The fusion index was calculated as the number of nuclei in myotubes divided by the total number of nuclei counted and average number of nuclei per myotube was the number of nuclei in myotubes divided by number of myotubes.
Quantitative real-time polymerase chain reaction
Total RNA was extracted from the tissues and myoblasts using TRIzol Reagent (Invitrogen, Carlsbad, CA, USA) and RNApreppurekits (Tiangen, Beijing, China), respectively. RNA was isolated from six replicated breast and thigh muscle samples from each of the previously noted times of embryonic development and post-hatching. RNA was also collected from triplicate wells of chicken primary myoblast cultures at 24 h, 48 h, and 72 h of proliferation, and at 24 h, 72 h, and 144 h of differentiation. cDNA was generated from 2 μg of total RNA in a final volume of 20 μL following kit instructions (Tiangen, China). Quantitative polymerase chain reaction (qPCR) was performed in triplicate using the instructions of SuperRealPreMix Plus kit (Tiangen, China) with 1 μL cDNA template, 0.6 μL gene specific primers, 10 μL 2×buffer, 0.4 μL 50×ROX Reference DyeGreen Master Mix, in a final volume of 20 μL, and a 7500 Real Time PCR System (Applied Biosystems, Foster City, CA, USA). Initial denaturing was at 95°C for 15 minutes, and was followed by 40 cycles of 95°C for 10 seconds, 55°C for 31 seconds, and 72°C for 32 seconds. Primers were designed (Premier Primer 5) on the basis of GenBank chicken sequences (Table 1).
Table 1.
Gene | GenBank accession no. | Sequence (5′ 3′) | Size (bp) |
---|---|---|---|
β-actin | NM_205518 | F: GAGAAATTGTGCGTGACATCA R: CCTGAACCTCTCATTGCCA |
152 |
HDAC2 | NM_204831 | F: GGGACCTTAGGGACATTGGT R: CTGGGCTGGTACATCTCCA |
139 |
PAX7 | NM_205065 | F: CATCCTGGGCGACAAAG R: TGCTCGGCAGTGAAAGTG |
114 |
MYOD1 | NM_204214 | F: TCAACGAGGCCTTTGAGACC R: CCTGCAGGCTCTCGATGTAG |
111 |
HDAC2, histone deacetylase 2; PAX7, paired box 7; MYOD1, myogenic differentiation 1.
Data processing and analyses
Data were processed using software provided with the instrument and Microsoft Excel (Microsoft Corp., Redmond, WA, USA). Relative gene expression was calculated by the 2−ΔΔCT method, using β-actin as an internal standard with the confirmation of qPCR efficiency (Livak and Schmittgen, 2001). Therefore the ΔCT (CT, target gene−CT, beta actin) was calculated for each cDNA dilution over a 100-fold range and the data were fit through least-squares linear regression analysis. Differences between developmental stages for breast and thigh muscles, and fusion index, nuclei number and transcript abundance from cells in different periods were assessed by separate one-way analysis of variances according to the following model and Table 2 with Tukey’s honestly significant difference post-hoc tests to compare means.
Table 2.
Source of variation (SV) | Sums of squares (SS) | Degree of freedom (DF) | Mean square (MS) | F-ration |
---|---|---|---|---|
Treatment | J-1 | |||
Error | J (I-1) | |||
Total | JI-1 |
Where, is the effect of j-th treatment in i-th level, μ is the general mean, represents the effect of j-th treatment and ℰij means random error due to i-th level of the j-th treatments.
The expression between low and high growth muscles from the breast of chicken was calculated by the following model of independent sample t-test.
Where, X̄, si2 and ni are the mean, variance and size of the samples in groups (i = 1 and 2), respectively.
RESULTS
Relative expression profiles of HDAC2 in the embryonic and post-hatch stages
In breast muscle of chickens, the transcript abundance of HDAC2 increased significantly across embryonic periods (ED 14, 16, 18, and 21) and there were differences between all sampling stages (ED 14 to 16, ED 16 to 18, and ED 18 to 21) (Figure 1). The progressive increase between adjacent sampling stages in thigh muscle was not significant but the differences of ED between 14 and 18, and 14 and 21 were significant (Figure 1). Because myoblast hyperplasia continues across these embryonic stages and finishes at the time of hatch, a well defined process in chickens, these results suggest that HDAC2 possibly plays a role in myoblast hyperplasia in breast and thigh muscles.
For the post-hatch periods, HDAC2 was markedly decreased from d 7 to d 14 and then kept stable to d 28 (Figure 2A). The gene expression in thigh muscle decreased from d 1 to d 14, then kept stable to d 28 (Figure 2B). The most rapid growth of both breast and thigh muscles occurred between d 14 and d 21, when expression of HDAC2 was relatively low; this period of muscle growth is mainly due to hypertrophy of existing fibers to which there may be little contribution from HDAC2. Significant differential expression (p<0.05) observed between the muscles of lowest and highest growth of chickens at growing stage (Figure 2C).
Expression of HDAC2 during myoblast proliferation in vitro
The relative expression of the HDAC2 gene and marker gene PAX7 was determined by qPCR in chicken primary myoblasts. Reciprocal changes were demonstrated here in the abundances of HDAC2 to both cell numbers and those of PAX7 (Figure 3). There was a decrease in HDAC2 transcripts and an increase in PAX7 between 24 and 48 h while the number of myoblasts steadily increased until 72 h. The changes are consistent with a possible negative regulatory role of HDAC2on myoblast proliferation.
Myoblast differentiation and HDAC2 expression in vitro
The progressive changing of primary myoblasts (Figure 4A) into differentiated, multinucleated myotubes corresponded closely with changes in the cell fusion index (Figure 4B) and average number of nuclei per myotube (Figure 4C). The fusing of myoblasts having single nuclei into the multinucleated myotubes over time was reflected in the comparatively long linear arrays of nuclei (Figure 4A). Increases in the relative abundance of HDAC2 and MYOD1, most obvious from 24 to 72 h then followed by apparent decreases were very similar (Figure 4D). These results are consistent with a positive regulatory role of HDAC2on myoblast differentiation, especially during the first 72 h. When combined with the changes in HDAC2 expression obtained in vivo, it is suggested that HDAC2 likely influences myoblasts by reducing their proliferation and increasing differentiation.
DISCUSSION
With the aim of exploring a new gene with a possible important function in pre-hatch muscle development, the association of HDAC2 with skeletal muscle development in chickens was the present focus. There was continuous increase in HDAC2 expression in embryonic muscles indicating that this gene may play a role in the hyperplastic phase of skeletal muscle growth. Up-regulation of HDAC2 was identified previously in human urothelial tissues (Niegisch et al., 2013), and in cardiomyocytes of rat hearts (Nural-Guvener et al., 2014). Moresi et al. (2012) reported that HDAC2 was associated with skeletal muscle homeostasis and autophagy flux in mice. In another study, deletion of both cardiac-specific HDAC1 and HDAC2 genes in mice resulted up-regulation encoding skeletal muscle-specific contractile proteins (Montgomery et al., 2007). The study demonstrated that HDAC2 gene expressed significantly greater in fast growing birds than slow growing which indicating this gene might be associated with muscle growth. No clear evidence, however, showed that HDAC2 functioned in skeletal muscle development and its underlying mechanisms.
In the present study, the observed pattern of down-regulation of HDAC2 during myoblast proliferation suggested that this gene might play a possible negative regulatory role on myoblast proliferation and function in the hyperplastic phase of development of chicken skeletal muscle. This is not consistent with previous reports in cardiomyocytes which claimed that the absence of HDAC2 causes myocyte hyper-proliferation in embryonic development and proliferation of cardiomyocytes in mice (Montgomery et al., 2007; Zhu, 2010) and HDAC2, HOP homeobox (HOPX), and GATA binding protein 4 (GATA4) coordinately regulates cardiac myocyte proliferation during embryonic development (Trivedi et al., 2010). Inhibition of class I HDAC reduced proliferation of newborn pulmonary arterial smooth muscle cells in sheep (Yang et al., 2013) and mice, including cell cycle arrest in G1 phase and migration (Galletti et al., 2014).
The up-regulation of HDAC2 during myoblast differentiation in the current study suggests its having a positive role during hyperplasia when muscle development consists mainly of the formation of multinucleated myotubes to then form muscle fibers. The potential role of HDAC2 was identified in the differentiation process of rat PC12 cells (Bai et al., 2005), neuronal cells in the cerebellar cortex of mice (Yoo et al., 2013) and also embryonic nervous system gained in zebra fish (Brunmeir et al., 2009). Turgeon et al. (2013) showed that HDAC2 regulates intestinal epithelial cell differentiation in mice but its inactivation impairs epidermal regulator p63-dependent differentiation (LeBoeuf et al., 2010). HDAC2 activates the transcriptional program of myelination and induces Schwann cell differentiation (Jacob et al., 2011) and a similar role in oligodendrocyte differentiation in mice was shown (Ye et al., 2009). Histone deacetylase controlled, notch-mediated smooth muscle differentiation occurs in human vascular cells (Tang et al., 2012), and class I HDAC regulated mammalian epithelial differentiation and intestinal (Tou et al., 2004). The myogenic marker gene MYOD1 showed a similar pattern of expression with HDAC2 here, during the differentiation of myoblasts to myotubes. The expression of MYOD1 during differentiation of pre-hatch chicken myoblasts (Halevy et al., 2004) and in fetal mice (Nguyen et al., 2010) detected previously. The gene HDAC2 and its encoded enzyme is an important regulator of gene expression (Parbin et al., 2014) and eukaryotic transcription (Taunton et al., 1996). The present findings are consistent with HDAC2 being involved in both the proliferative and early differentiation stages of skeletal myogenesis in chickens. Further study, particularly of histone deacetylation of other genes involved in myogenesis, are indicated to expand knowledge of the relevant molecular mechanisms.
CONCLUSION
The quantification of HDAC2 expression in the present study confirms its association with skeletal muscle development in chickens, especially during the embryonic and also in growing periods. The in vitro study of HDAC2 in chicken primary myoblasts suggests possible negative and positive regulatory roles during cell proliferation and differentiation, respectively. These two aspects of skeletal muscle development interact to determine the extent of the myoblast population at hatching, and presumably the potential for subsequent muscle growth. Accordingly, HDAC2 can be identified as a novel candidate functional gene worthy of additional study for its potential value in molecular-assisted breeding of poultry.
ACKNOWLEDGMENTS
The authors would like to acknowledge Dr. W. Bruce Currie (Emeritus Professor, Cornell University, USA) for his assistance in preparing the manuscript. The research was supported by grants: the National Natural Science Foundation of China (31201797); the Agricultural Science and Technology Innovation Program (ASTIP-IAS04); the earmarked fund for modern agro-industry technology research system (CARS-42).
Footnotes
CONFLICT OF INTEREST
We certify that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.
REFERENCES
- Bai S, Ghoshal K, Datta J, Majumder S, Yoon SO, Jacob ST. DNA methyltransferase 3b regulates nerve growth factor-induced differentiation of PC12 cells by recruiting histone deacetylase 2. Mol Cell Biol. 2005;25:751–766. doi: 10.1128/MCB.25.2.751-766.2005. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- Bentzinger CF, Wang YX, Rudnicki MA. Building muscle: Molecular regulation of myogenesis. Cold Spring Harb Perspect Biol. 2012;4:a008342. doi: 10.1101/cshperspect.a008342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brunmeir R, Lagger S, Seiser C. Histone deacetylase 1 and 2-controlled embryonic development and cell differentiation. Int J Dev Biol. 2009;53:275–289. doi: 10.1387/ijdb.082649rb. [DOI] [PubMed] [Google Scholar]
- Galletti M, Cantoni S, Zambelli F, Valente S, Palazzini M, Manes A, Pasquinelli G, Mai A, Galiè N, Ventura C. Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration. Biochem Pharmacol. 2014;91:181–190. doi: 10.1016/j.bcp.2014.07.011. [DOI] [PubMed] [Google Scholar]
- Halevy O, Piestun Y, Allouh MZ, Rosser BW, Rinkevich Y, Reshef R, Rozenboim I, Wleklinski-Lee M, Yablonka-Reuveni Z. Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Dev Dyn. 2004;231:489–502. doi: 10.1002/dvdy.20151. [DOI] [PubMed] [Google Scholar]
- Jacob C, Christen CN, Pereira JA, Somandin C, Baggiolini A, Lötscher P, Özçelik M, Tricaud N, Meijer D, Yamaguchi T, Matthias P, Suter U. HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. Nat Neurosci. 2011;14:429–436. doi: 10.1038/nn.2762. [DOI] [PubMed] [Google Scholar]
- Lamey TM, Koenders A, Ziman M. Pax genes in myogenesis: Alternate transcripts add complexity. Histol Histopathol. 2004;19:1289–1300. doi: 10.14670/HH-19.1289. [DOI] [PubMed] [Google Scholar]
- LeBoeuf M, Terrell A, Trivedi S, Sinha S, Epstein JA, Olson EN, Morrisey EE, Millar SE. Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells. Dev Cell. 2010;19:807–818. doi: 10.1016/j.devcel.2010.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lin W, Hashimoto SI, Seo H, Shibata T, Ohta K. Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40. Genes Cells. 2008;13:255–268. doi: 10.1111/j.1365-2443.2008.01166.x. [DOI] [PubMed] [Google Scholar]
- Liu R, Sun Y, Zhao G, Wang F, Wu D, Zheng M, Chen J, Zhang L, Hu Y, Wen J. Genome-wide association study identifies loci and candidate genes for body composition and meat quality traits in Beijing-You chickens. PLoS One. 2013;8:e61172. doi: 10.1371/journal.pone.0061172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−Δ ΔCT method. Methods. 2001;25:402–408. doi: 10.1006/meth.2001.1262. [DOI] [PubMed] [Google Scholar]
- McKinsey TA, Zhang CL, Olson EN. Control of muscle development by dueling HATs and HDACs. Curr Opin Genet Dev. 2001;11:497–504. doi: 10.1016/s0959-437x(00)00224-0. [DOI] [PubMed] [Google Scholar]
- Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev. 2007;21:1790–1802. doi: 10.1101/gad.1563807. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moresi V, Carrer M, Grueter CE, Rifki OF, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN. Histone deacetylases 1 and 2 regulate autophagy flux and skeletal muscle homeostasis in mice. Proc Nat Acad Sci. 2012;109:1649–1654. doi: 10.1073/pnas.1121159109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nguyen TH, Bertrand MJ, Sterpin C, Achouri Y, De Backer OR. Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration. BMC Cell Biol. 2010;11:57. doi: 10.1186/1471-2121-11-57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niegisch G, Knievel J, Koch A, Hader C, Fischer U, Albers P, Schulz WA. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers. Urol Oncol-Semin Orig Investig. 2013;31:1770–1779. doi: 10.1016/j.urolonc.2012.06.015. [DOI] [PubMed] [Google Scholar]
- Nural-Guvener HF, Zakharova L, Nimlos J, Popovic S, Mastroeni D, Gaballa MA. HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation. Fibrogenesis Tissue Repair. 2014;7:10. doi: 10.1186/1755-1536-7-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parbin S, Kar S, Shilpi A, Sengupta D, Deb M, Rath SK, Patra SK. Histone deacetylases a saga of perturbed acetylation homeostasis in cancer. J Histochem Cytochem. 2014;62:11–33. doi: 10.1369/0022155413506582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rehfeldt C, Te Pas MFW, Wimmers K, Brameld JM, Nissen PM, Berri C, Valente LMP, Power DM, Picard B, Stickland NC, Oksbjerg N. Advances in research on the prenatal development of skeletal muscle in animals in relation to the quality of muscle-based food. 1. Regulation of myogenesis and environmental impact. Animal. 2011;5:703–717. doi: 10.1017/S1751731110002089. [DOI] [PubMed] [Google Scholar]
- Segré CV, Chiocca S. Regulating the regulators: The post-translational code of class I HDAC1 and HDAC2. Biomed Res Int. 20112011 doi: 10.1155/2011/690848. Article ID:690848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tang Y, Boucher JM, Liaw L. Histone deacetylase activity selectively regulates notch-mediated smooth muscle differentiation in human vascular cells. J Am Heart Assoc. 2012;1:e000901. doi: 10.1161/JAHA.112.000901. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taunton J, Hassig CA, Schreiber SL. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science. 1996;272:408–411. doi: 10.1126/science.272.5260.408. [DOI] [PubMed] [Google Scholar]
- Tou L, Liu Q, Shivdasani RA. Regulation of mammalian epithelial differentiation and intestine development by class I histone deacetylases. Mol Cell Biol. 2004;24:3132–3139. doi: 10.1128/MCB.24.8.3132-3139.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Trivedi CM, Zhu W, Wang Q, Jia C, Kee HJ, Li L, Hannenhalli S, Epstein JA. Hopx and Hdac2 interact to modulate Gata4 acetylation and embryonic cardiac myocyte proliferation. Dev Cell. 2010;19:450–459. doi: 10.1016/j.devcel.2010.08.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turgeon N, Blais M, Gagné JM, Tardif V, Boudreau F, Perreault N, Asselin C. HDAC1 and HDAC2 restrain the intestinal inflammatory response by regulating intestinal epithelial cell differentiation. PLoS One. 2013;8:e73785. doi: 10.1371/journal.pone.0073785. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Velleman SG. Muscle development in the embryo and hatchling. Poult Sci. 2007;86:1050–1054. doi: 10.1093/ps/86.5.1050. [DOI] [PubMed] [Google Scholar]
- Yang Q, Dahl MJ, Albertine KH, Ramchandran R, Sun M, Raj JU. Role of histone deacetylases in regulation of phenotype of ovine newborn pulmonary arterial smooth muscle cells. Cell Prolif. 2013;46:654–664. doi: 10.1111/cpr.12076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ye F, Chen Y, Hoang T, Montgomery RL, Zhao XH, Bu H, Lu QR. HDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin–TCF interaction. Nat Neurosci. 2009;12:829–838. doi: 10.1038/nn.2333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoo JYJ, Larouche M, Goldowitz D. The Expression of HDAC1 and HDAC2 during cerebellar cortical development. Cerebellum. 2013;12:534–546. doi: 10.1007/s12311-013-0459-x. [DOI] [PubMed] [Google Scholar]
- Zhu W. PhD Thesis. University of Pennsylvania; Philadelphia, PA, USA: 2010. Mechanisms of Hdac2 Function in the Regulation of Adult Cardiac Hypertrophy and Embryonic Myocyte Proliferation. [Google Scholar]